Immunologic Status of Patients in Remission from Hodgkin’s Disease and Disseminated Malignancies

Immunologic Status of Patients in Remission from Hodgkin’s Disease and Disseminated Malignancies

The immunologic phenotypes of peripheral blood lymphocytes of 20 patients cured of Hodgkin’s disease (Group I) and of 20 patients cured of diverse, disseminated malignancies (Group II) were compared. Eleven patients in Group I had an increase in circulating B lymphocytes, and 6 patients in Group II...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of the medical sciences 1987-06, Vol.293 (6), p.366-370
Hauptverfasser: Shapiro, Charles M., Beckmann, Enrique, Christiansen, Neal, Bitran, Jacob D., Kozloff, Mark, Billings, Arthur A., Telfer, Margaret C.
Format: Artikel
Sprache:eng
Schlagworte:
Biological and medical sciences
Cancer
Hodgkin’s Disease
Host-tumor relations. Immunology. Biological markers
Immunologic Phenotypes
Medical sciences
T4/T8 Lymphocyte Ratio
Tumors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 370
container_issue 6
container_start_page 366
container_title The American journal of the medical sciences
container_volume 293
creator Shapiro, Charles M.
Beckmann, Enrique
Christiansen, Neal
Bitran, Jacob D.
Kozloff, Mark
Billings, Arthur A.
Telfer, Margaret C.
description The immunologic phenotypes of peripheral blood lymphocytes of 20 patients cured of Hodgkin’s disease (Group I) and of 20 patients cured of diverse, disseminated malignancies (Group II) were compared. Eleven patients in Group I had an increase in circulating B lymphocytes, and 6 patients in Group II had a decrease in this lymphocyte subset (0.0005
doi_str_mv 10.1097/00000441-198706000-00004
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00000441_198706000_00004</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002962915367549</els_id><sourcerecordid>S0002962915367549</sourcerecordid><originalsourceid>FETCH-LOGICAL-c260t-8e618f7fdcb089ee137a77a597f84aa59cfe16929adfc2f725b81990b9d830f3</originalsourceid><addsrcrecordid>eNqFUEtOwzAUtBBIlMIdvGAbsJ00tpdQPq1UBILuI8efypDYVV6KxI5rcD1OgtNCt7zNPI9mbM8ghCm5oETySzJMUdCMSsFJmQ7ZljlAIzrJRcakJIdolCiWyZLJY3QC8EoIZYLmI1TP23YTYhNXXuOXXvUbwNHhJ9V7G3rAPuBn23oAHwN2XWzxLJrVmw_fn1-AbzxYBRarYIYdkjKo3hr8oBq_Cipob-EUHTnVgD37xTFa3t0up7Ns8Xg_n14tMs1K0mfCllQ47oyuiZDW0pwrztVEcicKlVA7S0vJpDJOM8fZpBY0haulETlx-RiJ3bW6iwCdddW6863qPipKqqGq6q-qal_VliqS9XxnXSvQqnHd8HHY-wUTBadlkl3vZDalePe2qyDlC9oa31ndVyb6_9_6AawBf3E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Immunologic Status of Patients in Remission from Hodgkin’s Disease and Disseminated Malignancies</title><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Shapiro, Charles M. ; Beckmann, Enrique ; Christiansen, Neal ; Bitran, Jacob D. ; Kozloff, Mark ; Billings, Arthur A. ; Telfer, Margaret C.</creator><creatorcontrib>Shapiro, Charles M. ; Beckmann, Enrique ; Christiansen, Neal ; Bitran, Jacob D. ; Kozloff, Mark ; Billings, Arthur A. ; Telfer, Margaret C.</creatorcontrib><description>The immunologic phenotypes of peripheral blood lymphocytes of 20 patients cured of Hodgkin’s disease (Group I) and of 20 patients cured of diverse, disseminated malignancies (Group II) were compared. Eleven patients in Group I had an increase in circulating B lymphocytes, and 6 patients in Group II had a decrease in this lymphocyte subset (0.0005&lt;p&lt;0.0025). The T8 lymphocyte subset was increased in four patients in Group I and decreased in five patients in Group II (0.005&lt;p&lt;0.0125). The T4/T8 lymphocyte ratio was less than 1.0 in eight patients in Group I and in no patients in Group II (p&lt;0.001). These statistically significant differences between the two groups were unrelated to type or duration of therapy, and thus suggest basic biologic differences between the immune status of cured Hodgkin’s disease patients and cured patients with other malignancies.</description><identifier>ISSN: 0002-9629</identifier><identifier>EISSN: 1538-2990</identifier><identifier>DOI: 10.1097/00000441-198706000-00004</identifier><identifier>CODEN: AJMSA9</identifier><language>eng</language><publisher>Hagerstown, MD: Elsevier Inc</publisher><subject>Biological and medical sciences ; Cancer ; Hodgkin’s Disease ; Host-tumor relations. Immunology. Biological markers ; Immunologic Phenotypes ; Medical sciences ; T4/T8 Lymphocyte Ratio ; Tumors</subject><ispartof>The American journal of the medical sciences, 1987-06, Vol.293 (6), p.366-370</ispartof><rights>1987 Southern Society for Clinical Investigation</rights><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c260t-8e618f7fdcb089ee137a77a597f84aa59cfe16929adfc2f725b81990b9d830f3</citedby><cites>FETCH-LOGICAL-c260t-8e618f7fdcb089ee137a77a597f84aa59cfe16929adfc2f725b81990b9d830f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8284716$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Shapiro, Charles M.</creatorcontrib><creatorcontrib>Beckmann, Enrique</creatorcontrib><creatorcontrib>Christiansen, Neal</creatorcontrib><creatorcontrib>Bitran, Jacob D.</creatorcontrib><creatorcontrib>Kozloff, Mark</creatorcontrib><creatorcontrib>Billings, Arthur A.</creatorcontrib><creatorcontrib>Telfer, Margaret C.</creatorcontrib><title>Immunologic Status of Patients in Remission from Hodgkin’s Disease and Disseminated Malignancies</title><title>The American journal of the medical sciences</title><description>The immunologic phenotypes of peripheral blood lymphocytes of 20 patients cured of Hodgkin’s disease (Group I) and of 20 patients cured of diverse, disseminated malignancies (Group II) were compared. Eleven patients in Group I had an increase in circulating B lymphocytes, and 6 patients in Group II had a decrease in this lymphocyte subset (0.0005&lt;p&lt;0.0025). The T8 lymphocyte subset was increased in four patients in Group I and decreased in five patients in Group II (0.005&lt;p&lt;0.0125). The T4/T8 lymphocyte ratio was less than 1.0 in eight patients in Group I and in no patients in Group II (p&lt;0.001). These statistically significant differences between the two groups were unrelated to type or duration of therapy, and thus suggest basic biologic differences between the immune status of cured Hodgkin’s disease patients and cured patients with other malignancies.</description><subject>Biological and medical sciences</subject><subject>Cancer</subject><subject>Hodgkin’s Disease</subject><subject>Host-tumor relations. Immunology. Biological markers</subject><subject>Immunologic Phenotypes</subject><subject>Medical sciences</subject><subject>T4/T8 Lymphocyte Ratio</subject><subject>Tumors</subject><issn>0002-9629</issn><issn>1538-2990</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><recordid>eNqFUEtOwzAUtBBIlMIdvGAbsJ00tpdQPq1UBILuI8efypDYVV6KxI5rcD1OgtNCt7zNPI9mbM8ghCm5oETySzJMUdCMSsFJmQ7ZljlAIzrJRcakJIdolCiWyZLJY3QC8EoIZYLmI1TP23YTYhNXXuOXXvUbwNHhJ9V7G3rAPuBn23oAHwN2XWzxLJrVmw_fn1-AbzxYBRarYIYdkjKo3hr8oBq_Cipob-EUHTnVgD37xTFa3t0up7Ns8Xg_n14tMs1K0mfCllQ47oyuiZDW0pwrztVEcicKlVA7S0vJpDJOM8fZpBY0haulETlx-RiJ3bW6iwCdddW6863qPipKqqGq6q-qal_VliqS9XxnXSvQqnHd8HHY-wUTBadlkl3vZDalePe2qyDlC9oa31ndVyb6_9_6AawBf3E</recordid><startdate>198706</startdate><enddate>198706</enddate><creator>Shapiro, Charles M.</creator><creator>Beckmann, Enrique</creator><creator>Christiansen, Neal</creator><creator>Bitran, Jacob D.</creator><creator>Kozloff, Mark</creator><creator>Billings, Arthur A.</creator><creator>Telfer, Margaret C.</creator><general>Elsevier Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>198706</creationdate><title>Immunologic Status of Patients in Remission from Hodgkin’s Disease and Disseminated Malignancies</title><author>Shapiro, Charles M. ; Beckmann, Enrique ; Christiansen, Neal ; Bitran, Jacob D. ; Kozloff, Mark ; Billings, Arthur A. ; Telfer, Margaret C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c260t-8e618f7fdcb089ee137a77a597f84aa59cfe16929adfc2f725b81990b9d830f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Biological and medical sciences</topic><topic>Cancer</topic><topic>Hodgkin’s Disease</topic><topic>Host-tumor relations. Immunology. Biological markers</topic><topic>Immunologic Phenotypes</topic><topic>Medical sciences</topic><topic>T4/T8 Lymphocyte Ratio</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shapiro, Charles M.</creatorcontrib><creatorcontrib>Beckmann, Enrique</creatorcontrib><creatorcontrib>Christiansen, Neal</creatorcontrib><creatorcontrib>Bitran, Jacob D.</creatorcontrib><creatorcontrib>Kozloff, Mark</creatorcontrib><creatorcontrib>Billings, Arthur A.</creatorcontrib><creatorcontrib>Telfer, Margaret C.</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><jtitle>The American journal of the medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shapiro, Charles M.</au><au>Beckmann, Enrique</au><au>Christiansen, Neal</au><au>Bitran, Jacob D.</au><au>Kozloff, Mark</au><au>Billings, Arthur A.</au><au>Telfer, Margaret C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunologic Status of Patients in Remission from Hodgkin’s Disease and Disseminated Malignancies</atitle><jtitle>The American journal of the medical sciences</jtitle><date>1987-06</date><risdate>1987</risdate><volume>293</volume><issue>6</issue><spage>366</spage><epage>370</epage><pages>366-370</pages><issn>0002-9629</issn><eissn>1538-2990</eissn><coden>AJMSA9</coden><abstract>The immunologic phenotypes of peripheral blood lymphocytes of 20 patients cured of Hodgkin’s disease (Group I) and of 20 patients cured of diverse, disseminated malignancies (Group II) were compared. Eleven patients in Group I had an increase in circulating B lymphocytes, and 6 patients in Group II had a decrease in this lymphocyte subset (0.0005&lt;p&lt;0.0025). The T8 lymphocyte subset was increased in four patients in Group I and decreased in five patients in Group II (0.005&lt;p&lt;0.0125). The T4/T8 lymphocyte ratio was less than 1.0 in eight patients in Group I and in no patients in Group II (p&lt;0.001). These statistically significant differences between the two groups were unrelated to type or duration of therapy, and thus suggest basic biologic differences between the immune status of cured Hodgkin’s disease patients and cured patients with other malignancies.</abstract><cop>Hagerstown, MD</cop><pub>Elsevier Inc</pub><doi>10.1097/00000441-198706000-00004</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9629
ispartof The American journal of the medical sciences, 1987-06, Vol.293 (6), p.366-370
issn 0002-9629
1538-2990
language eng
recordid cdi_crossref_primary_10_1097_00000441_198706000_00004
source Journals@Ovid Complete; Alma/SFX Local Collection
subjects Biological and medical sciences
Cancer
Hodgkin’s Disease
Host-tumor relations. Immunology. Biological markers
Immunologic Phenotypes
Medical sciences
T4/T8 Lymphocyte Ratio
Tumors
title Immunologic Status of Patients in Remission from Hodgkin’s Disease and Disseminated Malignancies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T17%3A19%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunologic%20Status%20of%20Patients%20in%20Remission%20from%20Hodgkin%E2%80%99s%20Disease%20and%20Disseminated%20Malignancies&rft.jtitle=The%20American%20journal%20of%20the%20medical%20sciences&rft.au=Shapiro,%20Charles%20M.&rft.date=1987-06&rft.volume=293&rft.issue=6&rft.spage=366&rft.epage=370&rft.pages=366-370&rft.issn=0002-9629&rft.eissn=1538-2990&rft.coden=AJMSA9&rft_id=info:doi/10.1097/00000441-198706000-00004&rft_dat=%3Celsevier_cross%3ES0002962915367549%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0002962915367549&rfr_iscdi=true